PACIFIC Research Study for Seizures

The PACIFIC Study is a clinical trial for a drug called LP352. This study will assess the safety and tolerability of this drug as well as examine changes in seizure frequency over the 90-day treatment period. The study plans to enroll approximately 50 participants with a variety of treatment-resistant seizures that fall into the category of DEEs. There is no cost to participate in this clinical study.

LGS is tough. Finding information shouldn’t be. That is why we provide information about clinical trials in LGS. We hope you find this information useful as you navigate your LGS journey.


Additional Information:

View the PACIFIC Study Fact Sheet

Visit the PACIFIC Study Clinical Webpage 

 


The information here is not intended to provide diagnosis, treatment, or medical advice and should not be considered a substitute for advice from a healthcare professional. The content provided is for informational purposes only. LGS Foundation is not responsible for actions taken based on the information included on this webpage. Please consult with a physician or other healthcare professional regarding any medical or health related diagnosis or treatment options.


Updated 9/30/22